Continuing Medical EducationHemangiomas of infancy☆,☆☆,★,★★,♢
Section snippets
Epidemiology
HOI or their precursors can be identified in 1.1% to 2.6% of term neonates,5, 6 and their frequency is estimated to be as high as 10% to 12% within the first year of life.7, 8 They occur in children of all races, but may be less common in those of African or Asian descent. For unclear reasons, female neonates are more likely to be affected than male neonates at rates of 3 to 5:1.9 HOI are also more common in premature infants; increased prevalence correlates with both decreasing gestational age
Pathology and pathogenesis
On routine histology, proliferating HOI are composed of masses of plump, rapidly dividing endothelial cells with and without lumens. Multilamination of the basement membrane is also seen.1 As involution progresses, the vascular lumens dilate, endothelial cells flatten, and fibrous tissue is deposited, giving the hemangioma a lobular architecture. Fully involuted HOI contain few capillary-like feeding vessels and draining veins with flattened endothelium in a stroma of fibrofatty tissue,
Clinical features and natural history
The natural history of growth and regression of HOI was first described by Lister in 1938.38 These features have now been well characterized, but the enormous spectrum of severity, from tiny banal lesions to large and endangering ones, makes predictions of behavior and prognosis in individual patients difficult, especially in very young infants, in whom the most dramatic growth is likely to occur. The growth characteristics of HOI are often divided into phases: nascent, proliferating,
Sites of involvement
Although HOI may occur on any part of the body, they demonstrate a striking predilection for the head and neck region. In a large series, 60% of HOI occurred on the head and neck, followed by 25% on the trunk, and 15% on extremities.39 Furthermore, facial HOI seem to be nonrandomly distributed and occur in 2 morphologic forms. The majority are focal tumorlike lesions that tend to occur near lines of embryonic fusion. Less commonly, they involve a region of skin corresponding to a derivation
Worrisome presentations
Although the majority of HOI are localized and pose no immediate or long-term threat, a significant minority can cause serious morbidity. Early recognition of these problematic lesions, coupled with prompt intervention, may help to minimize future complications. Certainly, HOI in young infants warrant more attention as their growth pattern may be unpredictable. Also, HOI near ocular or periorificial locations are more likely to create complications. Finally, segmental HOI may be associated with
Differential diagnosis
Using the guidelines established by Finn, Mulliken, and Glowacki,39 more than 90% of vascular anomalies can be classified as hemangiomas or vascular malformations by history and physical examination alone. In a minority of cases, the diagnosis may be in question. A diverse group of conditions may mimic HOI (Table IV).
Other vascular anomalies and tumors Capillary malformation Venous malformation Lymphatic malformation Arteriovenous malformation NICH RICH
Imaging studies
Although many radiologists are unfamiliar with the use of imaging studies to differentiate HOI from vascular malformations or other soft-tissue tumors, several key reference have recently been published delineating characteristic radiologic findings.81, 82, 83 Noninvasive imaging studies such as Doppler ultrasound, computed tomography (CT), and MRI may be helpful in differentiating HOI from vascular malformations or other soft-tissue tumors. Invasive studies such as arteriography are best
Management and treatment
The management of HOI is controversial for several reasons.84 Perhaps foremost is the wide spectrum of clinical disease. This combined with the potential for rapid change in early infancy, can cause great difficulty in predicting which hemangiomas are innocuous and which will prove a real threat. In addition, randomized controlled trials or solid evidence-based studies of treatments and associated outcomes are sorely lacking. Some experts take an aggressive stance, favoring early intervention
Conclusions
HOI are common benign tumors of childhood, distinguished by their characteristic proliferation and involution. New findings regarding their pathogenesis, including newly described staining for GLUT1, point to a unique vascular phenotype rather than an overgrowth of the cutaneous vasculature. Dysregulation in vascular homeostasis may also help explain their development. HOI are extremely heterogeneous, and although most are relatively small and inconsequential, a significant minority may be
References (131)
- et al.
Vascular tumors and vascular malformations: evidence for an association
J Am Acad Dermatol
(2000) - et al.
Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations
J Surg Res
(1996) - et al.
GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas
Hum Pathol
(2000) Angiogenesis and the skin: a primer
J Am Acad Dermatol
(1996)- et al.
Are infantile hemangiomas of placental origin?
Ophthalmology
(2002) - et al.
Increased tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells
Am J Pathol
(2001) - et al.
Clusterin/apoJ expression during the development of hemangioma
Hum Pathol
(2000) The natural history of strawberry nevi
Lancet
(1938)- et al.
Capillary hemangioma (infantile periocular hemangioma)
Surv Ophthalmol
(1994) - et al.
Periorbital hemangiomas
Dermatol Clin
(1992)
Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a “beard” distribution
J Pediatr
Association of facial hemangiomas with Dandy-Walker and other posterior fossa malformations
J Pediatr
The many faces of PHACE syndrome
J Pediatr
Perineal hemangioma, anorectal malformation, and genital anomaly: a new association?
J Pediatr Surg
The developmental field concept in clinical genetics
J Pediatr
Benign neonatal hemangiomatosis
J Am Acad Dermatol
Hepatic vascular anomalies in infancy: a twenty-seven-year experience
J Pediatr
Hepatic hemangioendothelioma: clinical experience and management strategy
J Pediatr Surg
Hepatic hemangioendothelioma associated with production of humoral thyrotropin-like factor
J Pediatr
Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas
J Pediatr
Congenital hemangioma: evidence of accelerated involution
J Pediatr
Diagnostic imaging in the evaluation of vascular birthmarks
Dermatol Clin
Guidelines of care for hemangiomas of infancy
J Am Acad Dermatol
Ulcerated hemangiomas: clinical characteristics and response to therapy
J Am Acad Dermatol
Successful treatment of juvenile hemangiomas with prednisone
J Pediatr
Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics
Plast Reconstr Surg
Vascular tumors and vascular malformations (new issues)
Adv Dermatol
Vascular birthmarks: hemangiomas and malformations
Birthmarks in infants
Arch Dermatol
The incidence of birthmarks in the neonate
Pediatrics
Strawberry hemangiomas: the natural history of the untreated lesion
Calif Med
Cutaneous hemangiomas in premature and mature infants
Acta Paediatr
Vascular anomalies
Curr Probl Surg
Epidemiology of strawberry haemangioma in low birthweight infants
Br J Dermatol
Strawberry hemangioma in preterm infants
Pediatr Dermatol
An increased incidence of haemangiomas in infants born following chorionic villus sampling (CVS)
Prenat Diagn
Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait
Arch Dermatol
Cellular hemangiomas (“hemangioendotheliomas”) in infants: light microscopic, immunohistochemical, and ultrastructural observations
Am J Surg Pathol
Mast cells in hemangiomas and vascular malformations
Pediatrics
Cellular markers that distinguish the phases of hemangioma during infancy and childhood
J Clin Invest
Cellular and extracellular markers of hemangioma
Plast Reconstr Surg
E-selectin is present in proliferating endothelial cells in human hemangiomas
Am J Pathol
A unique microvascular phenotype shared by juvenile hemangiomas and human placenta
Arch Dermatol
Infantile hemangiomas: speculation on placental trophoblastic origin
Arch Dermatol
Clinical applications of research on angiogenesis
N Engl J Med
Vasculogenesis, angiogenesis, hemangiomas, and vascular malformations
Am J Med Genet
Vascular endothelial growth factor confers a growth factor advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas
Am J Pathol
Genetic mapping of a novel familial form of infantile hemangioma
Am J Med Genet
Evidence for loss of heterozygosity of 5q in sporadic haemangiomas: are somatic mutations involved in haemangioma formation?
J Clin Pathol
Clonality and altered behavior of endothelial cells from hemangiomas
J Clin Invest
Cited by (353)
Surgical Treatment of Vascular Anomalies
2022, Dermatologic ClinicsNormal vascular identity (arteries, veins, and lymphatics) and malformations
2022, The Vasculome: From Many, OneLobular capillary hemangioma of palatal mucosa of an infant
2021, Journal of Pediatric Surgery Case ReportsSurgical management of intramuscular hemangioma of left masseter muscle: A case report
2024, National Journal of Maxillofacial SurgeryA Curious Case of Multiple Lower Limb Swellings
2024, Indian Journal of Plastic SurgeryRapid low-cost hyperspectral imaging system for quantitative assessment of infantile hemangioma
2024, Journal of Biophotonics
- ☆
Funding sources: None.
- ☆☆
Conflict of interest: None identified.
- ★
Reprints not available from authors.
- ★★
Correspondence: Ilona J. Frieden, MD, Department of Dermatology, University of California, San Francisco, 1701 Divisadero St, 3rd Floor, San Francisco, CA 94143-0316. E-mail: [email protected].
- ♢
0190-9622/2003/$30.00 + 0